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THE proliferation of T-lymphocytes is dependent upon
their ability to synthesize and secrete the cytokine,
interleukin-2, and to express cell surface receptors for
interleukin-2 and transferrin. We have previously reported
that certain fatty acids inhibit mitogen-stimulated
T-lymphocyte proliferation. We now report that un-
saturated fatty acids decrease the concentration of
interleukin-2 in the culture medium of such cells by up
to 45%. This suggests that unsaturated fatty acids inhibit
lymphocyte proliferation by suppressing interleukin-2
production. However, lymphocyte proliferation was only
partially restored by addition of exogenous interleukin-2
to cell culture medium in the presence of unsaturated fatty
acids, indicating that these fatty acids also affect other
processes involved in the control ofproliferation. Saturated
fatty acids, which also inhibit lymphocyte proliferation,
did not affect the interleukin-2 concentration in the culture
medium suggesting a different mechanism for their action.
Neither saturated nor unsaturated fatty acids affected the
expression of the interleukin-2 receptor by mitogen-
stimulated lymphocytes. In contrast, unsaturated fatty
acids decreased expression of the transferrin receptor by
up to 50%. These observations suggest that the mechanism
by which unsaturated fatty acids inhibit lymphocyte
proliferation involves suppression of interleukin-2 produc-
tion and of transferrin receptor expression. The mechan-
ism for the inhibitory action of saturated fatty acids is not
clear.
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Introduction
T-lymphocytes are activated by interaction with
stimuli such as antigens, mitogens or antibodies
directed against cell surface structures. Activation
of T-cells results in production of interleukin-2
(IL-2) and appearance on the cell surface of
receptors for IL-2 and for transferrin. Although the
expression of IL-2 receptors precedes that of
transferrin receptors, 1’2 the appearance of both types
of receptor is crucial for subsequent proliferation
of the activated T-cell.2-4 Proliferation of such cells
also requires the continued production of IL-2. 5’6
Therefore, a decrease in the rate of IL-2 production
or in the expression of the receptors for IL-2 or
for transferrin would be expected to decrease the
rate of T-lymphocyte proliferation. Indeed, defects
in 1L-2 production result in a decreased in vitro
response to mitogens,
5-7 the loss of high aflqnity
IL-2 receptors leads to termination of T-cell
proliferation in vitro,-
and blocking of transferrin
receptors with monoclonal antibodies inhibits
DNA synthesis and cell division. 2’4
(C) 1992 Rapid Communications of Oxford ktd
We have shown that a number of fatty acids at
physiological concentrations can inhibit the prolif-
eration of mitogen-stimulated rat lymphocytes in
culture,l All nine fatty acids tested inhibited the
response to concanavalin A (Con A) but the extent
of inhibition was dependent upon the fatty acid
concentration used, the time of fatty acid addition
to the culture medium and the duration of exposure
of the cells to the fatty acid. Generally, unsaturated
fatty acids were more inhibitory than saturated fatty
acids; the greatest inhibition of proliferation
was caused by eicosapentaenoate (20:5 n-3) or
arachidonate (20:4 n-6) and the least inhibition was
caused by myristate (14:0) or palmitate (16:0).
The mechanism by which fatty acids affect
lymphocyte proliferation is unknown. Therefore,
the effects of various fatty acids on some of the
known requirements for proliferation of mitogen-
stimulated rat lymphocytes in culture (i.e. IL-2
production and expression of receptors for IL-2 and
for transferrin) were investigated. The fatty acids
used were myristate, palmitate, stearate (18:0),
oleate (18:1 n-9), linoleate (18:2 n-6), 0-linolenate
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(18:3 n-3), arachidonate, eicosapentaenoate and
docosahexaenoate (22:6 n-3).
Materials and Methods
Materials: These were obtained from sources as
described previously.
11 CTLL-2 and G2 cell lines,
recombinant human IL-2 (Cetus) and the IL-2
receptor blocking antibody (NDS 63) were
generous gifts from Dr Maggie Dallman, Nuflqeld
Department of Surgery, John Radcliffe Hospital,
Headington, Oxford. Monoclonal antibodies (MRC
OX-21, MRC OX-26, MRC OX-39) and fluorescein
isothiocyanate-labelled rabbit anti-mouse IgG
(RAM-FITC) were generous gifts from the MRC
Cellular Immunology Unit, Sir William Dunn
School of Pathology, University of Oxford,
Oxford. Fatty acid-bovine serum albumin (BSA)
complexes were formed as described previously.
11
T-mphocyte proliferation assay: Male Wistar rat cervical
lymph node cells were isolated, purified and
cultured as described elsewhere.1 Briefly, the cells
were cultured at 37C in an air/CO2 atmosphere
(19:1) in 96-well microtitre culture plates (approx.
5 10 cells/well and a final culture volume of
200/1) in a HEPES-buffered RPMI medium
supplemented with 10% (v/v) foetal calf serum,
2 mM glutamine, 5/zg/ml Con A, 100/M fatty acid
(added as a complex with BSA) and antibiotics
(100 units/ml streptomycin and 200 units/ml peni-
cillin). In some experiments (see Results) the cell
culture medium also contained recombinant human
IL-2 (20units/ml). After 48 h, [6-3H]-thymidine
(0.2 #Ci/well) was added and the cells were cultured
for a further 18 h. The cells were then harvested
onto glass fibre filters which were washed and dried
using a Skatron Cell Harvester. [3H]-Thymidine
incorporation was measured by liquid scintillation
counting and was used to indicate cell prolifera-
tion.
12
Assay for IL-2 in culture media: The concentration of
IL-2 in lymphocyte culture media was determined
by bioassays which used the IL-2-dependent murine
CTLL-2 and rat G24 cell lines. The cell lines were
maintained in a HEPES-buered RPMI medium
supplemented with 10% foetal calf serum, 2 mM
glutamine, 25/,M 2-mercaptoethanol and re-
combinant human IL-2. Prior to their use in
the bioassays, CTLL-2 and G2 cells were collected
by centrifugation and washed three times in
IL-2-free medium.
After culture of lymphocytes for various times in
the conditions described above, the medium was
removed, serially diluted two-fold and 100/1
aliquots transferred to microtitre plate wells.
CTLL-2 or G2 cells (1 x 104/100 ul) were added to
each well. The plates were incubated for 18 h at
37C and then [6-H]-thymidine was added
(0.5/Ci/well). After a further 6 h incubation the
cells were harvested onto glass fibre filters, washed
and dried; the incorporation of [H]-thymidine into
DNA was measured. Recombinant human IL-2 was
used to construct a standard curve of thymidine
incorporation against IL-2 concentration. In some
experiments the response of the G2 cells to IL-2
was blocked using NDS 63, an antibody which
blocks the rat IL-2 receptor,
is Preliminary experi-
ments established that an NDS 63 concentration of
100/g/ml could completely block the response of
the G2 cell line to IL-2 (data not shown).
Anasis of IL-2 and transferrin receptor expression:
Lymphocytes were cultured as described above, but
at a concentration of 5 x 106 cells/well and a total
culture volume of 2 ml in 24-well culture plates.
After 48 h, the cells were removed and washed
twice in Ca2+- and Mgi+-supplemented phos-
phate-buered saline (PBS), pH 7.2, containing
0.1% BSA and 10 mM sodium azide. Approximately
106 cells were incubated for 20 min at 4C with
monoclonal antibodies to the IL-2 receptor (MRC
OX-39) or the transferrin receptor (MRC OX-26).
Incubation with a monoclonal antibody to the
human C3b activator protein (MRC OX-21) was
used as a negative control. The cells were then
washed twice with PBS and incubated for 20 min
at 4C with RAM-FITC. After washing twice with
PBS, the cells were suspended in ’FACS-Fix’ (2%
formaldehyde in PBS) and examined using a Becton
Dickinson FACScan fluorescence-activated cell
sorter (FACS). Fluorescence data were collected on
1 x 104 viable cells, using forward light scatter. The
distribution of fluorescently-labelled cells was
computed using standard methods.
Results
Fatty acid inhibition of IL-2 production: IL-2 was not
detectable in the medium of lymphocytes cultured
in the absence of Con A (Fig. 1). However, after
stimulation of the cells by Con A, the IL-2
concentration in the culture medium was markedly
increased (Fig. 1); it reached a maximum
concentration of approximately 8 units/ml after 24 h
of culture and remained high until at least 48 h (Fig.
1). The presence of BSA in the cell culture medium
did not affect the IL-2 concentration (Fig. 1).
Addition of myristate, palmitate or stearate to the
culture medium did not affect the IL-2 concentra-
tion (Table 1). In contrast, unsaturated fatty acids
decreased the IL-2 concentration in the cell culture
medium by up to 45% after either 24 h or 48 h of
culture (Table 1).
In addition to IL-2, the lymphocyte culture
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FIG. 1. The concentration of IL-2 in the culture medium of rat
lymphocytes. Rat lymph node lymphocytes were cultured for in the
absence (A) or presence (,, O) of Con A. In some cases the medium
was also supplemented with 100/M bovine serum albumin (O). At
various times the medium was removed, serially diluted two-fold and the
concentration of IL-2 determined using the CTLL-2 cell line (see
Materials and Methods). Data are the mean___SEM of twelve
determinations.
medium will contain other cytokines, including
interleukin-4 (IL-4). IL-2-dependent cell lines may
also respond to IL-4. Therefore, the specificity of
this bioassay for IL-2 was investigated by using the
G2 cell line and the NDS 63 antibody, which blocks
the IL-2 receptor on G2 cells. The response of G2
cells to IL-2 can be completely abolished using
NDS 63 (data not shown). The IL-2 concentrations
in lymphocyte culture media determined using the
G2 cell line were similar to those obtained with the
CTLL-2 cell line (Table 1). The specificity of these
measurements for IL-2 was confirmed; IL-2 was not
detected in the culture media if the G2-based
bioassay was performed in the presence of
100/g/ml NDS 63 (Table 1). Fatty acids themselves
had no effect upon thymidine incorporation into
either the CTLL-2 or G2 cell lines (data not shown).
Partial reversal offatty acid-induced inhibition of T-lymphocyte
proliferation by IL-2: If fatty acids cause inhibition of
T-lymphocyte proliferation by lowering the con-
centration of IL-2, it would be expected that the
addition of exogenous IL-2 would restore the
proliferative response. Therefore, lymphocytes
were cultured for 66 h in the presence of Con A,
fatty acid and recombinant human IL-2 (20
units/ml) and thymidine incorporation measured
over the final 18 h of culture. Addition of IL-2 to
control lymphocyte cultures (i.e. no fatty acid
added) had no effect on thymidine incorporation
(Table 2). In the presence of saturated fatty acids,
IL-2 addition did not affect thymidine incorporation
(Table 2). In contrast, in the presence of unsaturated
fatty acids, IL-2 addition increased thymidine
incorporation (Table 2). However, the restoration
of the proliferative response by IL-2 was only
partial; fatty acids retained part of their inhibitory
effect in the presence of IL-2 (Table 2).
Ejfect offatty acids on expression of the IL-2 and transferrin
receptors: The effect of fatty acids on the proportion
of cells expressing receptors for IL-2 or transferrin
was investigated using the MRC OX-39 and MRC
OX-26 monoclonal antibodies, respectively; a
monoclonal antibody to the human C3b activator
protein (MRC OX-21) was used as a negative
control. The proportion of cells staining positive
with MRC OX-21 was always less than 8%, even
following mitogenic stimulation.
The proportion of freshly prepared lymphocytes
Table 1. Effect of fatty acids on the concentration of L-2 in the culture medium of Con A-stimulated rat lymphocytes
Fatty acid IL-2 concentration (units/ml)
24 h 48 h 48 hb 48 h
None 7.9 _+ 0.4 (100) 6.2 _+ 0.2 (100) 6.3 _+ 0.2 (100) <0.5
Saturated
Myristate 8.5 _+ 0.4 (108) 6.0 4- 0.2 (97) 6.6 _+ 0.2 (104) <0.5
Palmitate 6.7 _+ 0.5 (85) 6.0 _+ 0.3 (97) 6.4 4- 0.4 (102) <0.5
Stearate 6.6 4- 0.6 (84) 5.6 _+ 0.4 (90) 6.2 4- 0.4 (98) <0.5
Unsaturated
Oleate 6.3 4- 0.3d (80) 4.7 ___
0.4d (76) 5.0 Jr- 0.2 (79) <0.5
Linoleate 6.2 4- 0.2 (78) 3.0 __+ 0.2 (48) 3.8 4- 0.3 (60) <0.5
Linolenate 6.3 4- 0.3 (79) 3.8 4- 0.4 (61) 3.6 ___
0.2 (57) <0.5
Arachidonate 5.4 Jr 0.2 (68) 3.7 4- 0.3 (60) 3.8 4- 0.5 (60) <0.5
Eicosapentaenoate 4.3 4- 0.3 (54) 3.6 4- 0.2 (58) 3.4 4- 0.3 (54) <0.5
Docosahexaenoate 4.4 4- 0.6 (56) 4.1 4- 0.3 (66) 4.2 4- 0.4 (67) <0.5
Rat lymph node lymphocytes were .cultured for 24 or 48 h in the presence of Con A and 100/M fatty acid-albumin complexes. The
medium was removed, serially diluted two-fold and the concentration of IL-2 determined using the CTLL-2 or G2b’c cell lines (see
Materials and Methods). Assays using the G2 cell line were performed in the absenceb or presence of 100 #g/ml IL-2 receptor
blocking antibody (NDS 63). Data are the mean 4- SEM of 12 or 6b’c determinations. Statistical significance vs. control (i.e. no
fatty acid addition)" dp< 0.01, ep < 0.001. Numbers in parentheses are IL-2 concentration as a percentage of the control mean.
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Table 2. Effect of fatty acids on Con A-stimulated lymphocyte proliferation in the
presence and absence of added L-2
Fatty acid Thymidine incorporation (dpm/well)
No addition Exogenous L-2
None 124798_+5415(100) 131655_+2540(100)
Saturated
Myristate 99 410 _+ 2 011 (80) 102 477 _+ 4 636b (78)
Palmitate 86 999 _+ 275b (70) 93 240 _+ 3 2045 (71)
Stearate 54 931 _+ 4 404b (44) 65 109 _+ 3 6025 (49)
Unsaturated
Oleate 47 407 _+ 5 192b (38) 67 421 _+ 6 573b,c (51)
Linoleate 37 968 _+ 2 651 b (30) 78 542 _+ 2 491 b,e (60)
Linolenate 52 256 _+ 5 023b (42) 80 472 4 213b,d (61)
Arachidonate 28 563 _+ 3 173b (23) 56 166 _+ 3 566b’e (43)
Eicosapentaenoate 16896 _+ 698b (14) 54070 _+ 2 561 b,e (41)
Docosahexaenote 43 896 _+ 4 704b (35) 66 509 _+ 2 5005,d (51)
Rat lymph node lymphocytes were cultured in the presence of Con A and 100 #M
fatty acid-albumin complexes. In some cases the medium was also supplemented
with recombinant human IL-2 (20 units/ml). Proliferation was assessed by the
incorporation of radioactive thymidine into DNA over the final 18 h of a 66 h culture
period. Data are the mean _+ SEM of six determinations. Statistical significance vs.
control cells (i.e. no fatty acid addition) ap < 0.01, bp < 0.001 VS. no IL-2 addition"
Cp < 0.05, dp< 0.01, ep < 0.001. Numbers in parentheses are thymidine
incorporation as a percentage of the control mean.
that were positive for IL-2 receptor expression was
2.5%. After culture for 48 h in the absence of Con
A 8.4% of cells were IL-2 receptor-positive. The
fluorescence profiles obtained for cells cultured in
the presence of Con A are shown in Fig. 2;
mitogenic stimulation resulted in an increase in IL-2
receptor-positive cells to 83.1% (Table 3). The
presence of fatty acids did not alter the proportion
of cells expressing the IL-2 receptor (Table 3).
The proportion of freshly prepared lymphocytes
which expressed the transferrin receptor was 5.6%.
After culture for 48 h in the absence of mitogen,
7.2% of cells were transferrin receptor-positive.
Mitogenic stimulation resulted in an increase in
transferrin receptor-positive cells to 32.9% (Table
3). Although the presence of saturated fatty acids
in the culture medium did not change the
percentage of cells that were transferrin receptor-
positive (Table 3), the presence of unsaturated fatty
b
l,ogo Ilu0rescence
FIG. 2. Immunofluorescent profiles of Con A-stimulated lymphocytes. Rat
lymph node lymphocytes were cultured in the presence of Con A. After
48 h the cells were washed and prepared for FACS analysis as described
in Materials and Methods. The cells were incubated with (a) MRC OX-21
(anti-human C3b activator protein), (b) MRC OX-39 (anti-lL-2 receptor) or
(c) MRC OX-26 (anti-transferrin receptor) and then stained with RAM-FITC.
Stained cells were analysed in a FACScan analyser and the percentage of
positive cells was determined by standard computerized methods.
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acids resulted in a decrease in this percentage (Table
3). The proportion of lymphocytes expressing the
transferrin receptor was decreased by 50% in the
presence of some polyunsaturated fatty acids (Table
3).
Table 3. Effect of fatty acids on the expression of receptors for
IL-2 and transferrin by Con A-stimulated rat lymphocytes





None + 83.1 32.9
Saturated
Myristate + 87.7 33.3
Palmitate + 80.3 31.6
Stearate + 83.0 31.8
Unsaturated
Oleate + 88.4 20.6
Linoleate + 81.4 24.0
Linolenate + 85.0 16.7
Arachidonate + 87.9 21.0
Eicosapentaenoate + 87.6 20.0
Docosahexaenoate + 87.6 18.1
Rat lymph node lymphocytes were cultured in the absence or
presence of Con A and 100 #M fatty acid-albumin complexes.
After 48 h the cells were collected, washed and incubated with
monoclonal antibodies to the IL-2 receptor or transferrin
receptor. After washing, the cells were incubated with
RAM-FITC. After further washing, the cells were examined by
FACS analysis. Data are the percentage of cells staining positive
for each receptor, and are for a single, representative, cell
preparation.Fatty acids and mphocyte function
Discussion
We have previously shown that fatty acids, in
particular polyunsaturated fatty acids, inhibit Con
A-stimulated proliferation of rat lymph node and
human peripheral blood lymphocytes in culture. 11’16
Fatty acids also inhibit lipopolysaccharide-stimu-
lated proliferation of rat lymph node lymphocytes.
17
In these studies, the fatty acids have been used at
physiological concentrations and are presented to
the cells as complexes with albumin, the means by
which they are transported in the circulation. Fatty
acids do not have a toxic effect since cell viability,
as measured by trypan blue exclusion, was similar
to that observed for cells cultured in the absence of
exogenously-added fatty acids.
1 Furthermore,
proliferation can be returned to normal if fatty acids
are removed from the medium (P. C. Calder,
unpublished data) or if a combination of fatty acids
is added to the culture medium. These observa-
tions indicate that inhibition of proliferation is not
due to a detergent or other toxic effect of the fatty
acids, and suggest that fatty acids exert their effects
by interfering with the normal signalling mechan-
isms that control lymphocyte proliferation.
The proliferation of lymphocytes requires an
increase in IL-2 secretion by activated T-cells and
the expression of the IL-2 and transferrin receptors
on the plasma membrane of such cells (see
Introduction). In this study, we have demonstrated
that unsaturated fatty acids lower the IL-2
concentration in the culture medium of mitogen-
stimulated lymphocytes (Table 1). This suggests
that the inhibitory effect of unsaturated fatty acids
on mitogen-stimulated T-cell proliferation is
mediated, at least in part, by the inhibition of IL-2
production. Addition of exogenous IL-2 did not
completely restore the proliferative response in the
presence of fatty acids (Table 2), suggesting that
there is at least one further component of the fatty
acid-induced inhibition and that this component is
independent of the suppression of IL-2 production.
Unsaturated fatty acids did not affect IL-2
receptor expression but they did suppress expres-
sion of the transferrin receptor (Table 3).
Expression of the transferrin receptor is induced by
interaction between IL-2 and its receptor.
2 Because
unsaturated fatty acids inhibited IL-2 production, it
was possible that the inhibition of transferrin
receptor expression was due to the decrease in IL-2
concentration. However, the inability of exogenous
IL-2 to restore the proliferative response in the
presence of fatty acids, indicates that fatty acids may
interfere with transferrin receptor expression by a
mechanism which is separate from their ability to
inhibit IL-2 production. Thus, it appears that
unsaturated fatty acids interfere with at least two
distinct steps in the T-cell proliferative process:
IL-2 production and transferrin receptor expres-
sion.
Saturated fatty acids did not affect the IL-2
concentration or the expression of receptors for
IL-2 or transferrin (Tables 1, 3). How saturated
fatty acids influence lymphocyte proliferation is not
known at present.
The eflects of unsaturated fatty acids upon the
proliferation of T-lymphocytes are similar to those
of prostaglandin E2 (PGE.), a well-documented
inhibitor of mitogen-stimulated lymphocyte prolif-
eration,
1-2 which inhibits both IL-2 produc-
tion
21-23 and transferrin receptor expression23,
whilst not affecting IL-2 receptor expression.
23 The
similarity of the eects of PGE2 and unsaturated
fatty acids suggests that the fatty acids may act via
formation of immunosuppressive eicosanoids, such
as PGE2. However, we have recently presented
strong evidence that the inhibitory eect of fatty
acids upon lymphocyte proliferation is independent
of eicosanoid production.
24
Many of the events involved in lymphocyte
activation and proliferation, including signal
transduction and receptor expression, are mem-
brane-associated and it is known that membrane
functions are influenced by the fatty acid
composition of the membrane phospholipids,
probably via changes in membrane fluidity. It has
recently been shown that during culture of activated
lymphocytes, specific changes in fatty acid composi-
tion and membrane fluidity occur;
2s these changes
may be an integral part of the proliferative response.
Lymphocytes readily incorporate fatty acids into
their lipids
26 and so the presence of an excess of one
fatty acid in the culture medium may result in
accumulation of that particular fatty acid in the
phospholipids of the plasma membrane which
would be expected to affect fluidity. Such a change
in membrane fluidity could affect the signal
transduction mechanisms which lead to synthesis of
IL-2 and receptors. Furthermore, newly synthesized
IL-2 must pass through the plasma membrane and
newly synthesized transferrin receptors must be
inserted into the plasma membrane. As such,
changes in the membrane fluidity could cause the
observed decreases in IL-2 production (Table 1) and
transferrin receptor expression (Table 3), resulting
in decreased lymphocyte proliferation (Table 2). In
support of this, it has been shown that other agents
which perturb membrane structure and/or fluidity
also inhibit IL-2 production by T-lymphocytes.
27 These agents include ethanol, cyclosporin A,
28
7,25-dihydroxycholestero129 and some carcino-
gens.’1 Cyclosporin A also suppresses transferrin
receptor expression.2’3
In addition to an effect mediated via altered
membrane fluidity, fatty acids could have a direct
effect on transferrin receptor expression. The
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transferrin receptor is post-translationally acylated
with palmitate
34 and it is known from work with a
cell-free system that other fatty acids can substitute
for palmitate.
35 The function of transferrin receptor
acylation is not known. However, the importance
of palmitoylation to membrane protein function is
known from other systems. For example, the H-ras
protein is palmitoylated and removal of the
palmitate or its replacement with a myristoyl
residue alters the affinity or anchoring of this
protein to the membrane, suggesting that the
acylation state can dramatically affect protein
function.36 Therefore, in the present study it is
possible that the palmitic acid residue, which may
be critical for transferrin receptor expression, has
been replaced by other acyl groups; this could result
in the down-regulation of transferrin receptor
expression observed in the presence of unsaturated
fatty acids (Table 3). Interestingly, the IL-2 receptor
is not acylated and its expression was not affected
by fatty acids.
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